SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2003 / Cilt: 3 - Sayı: 3

Farklı bir tip dumansız tütün kullanımının kardiyak parametreler üzerine etkisi: "Maraş otu"

Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder"

Gülizar SÖKMEN
Ç. Emre ÇAĞLAYAN
Ekrem AKSU
Aytekin GÜVEN
Ali ÇETİNKAYA
M. Akif BÜYÜKBEŞE
Nurhan KÖKSAL
Pages
230–235
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When they were compared to group III, deceleration time was also increased (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: A plant powder called "Maraş Powder" has been used widely instead of cigarette in the South-Eastern region of Turkey.
📊
Key Findings & Data:Methods: Forty-five Maraş Powder users (Group I), 32 persons who smoked cigarette (control-Group II) and 30 healthy persons neither smoking nor using Maraş Powder (Group III) were included into the study.
💡
Conclusion & Impact:When they were compared to group III, deceleration time was also increased (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: A plant powder called "Maraş Powder" has been used widely instead of cigarette in the South-Eastern region of Turkey. It was confirmed that this powder has been made of tobacco N. rustica L. Our aim was to investigate whether the use of Maraş Powder is as harmful as cigarette smoking or not. Methods: Forty-five Maraş Powder users (Group I), 32 persons who smoked cigarette (control-Group II) and 30 healthy persons neither smoking nor using Maraş Powder (Group III) were included into the study. Laboratory investigations, electrocardiography and echocardiography were performed in all participants of the study. For evaluation of the ventricular repolarization parameters, 50 mm/sec ECG recordings were used. Echocardiographic investigation was performed for assessment systolic and diastolic function. Results: No differences were found by means of ventricular repolarization parameters among the three groups (p>0.05). Echocardiographic investigation revealed similar systolic function results in all of the three groups. There was reduced early filling velocity of the left ventricle (p=0.03, p=0.02) and increased filling velocity of the atrial component (p=0.02, p=0.02) in group I and group II. When they were compared to group III, deceleration time was also increased (p

Özet

Amaç: Yurdumuzun Güneydoğu Anadolu bölgesinde "Maraş Otu" adı verilen bitkisel bir toz, sigara yerine yaygın olarak kullanılmaktadır. Bu tozun N. rustica L. tütününden yapıldığı tespit edilmiştir. Çalışmamız, Maraş Otu kullanımının sigara kadar zararlı olup olmadığını değerlendirmek amacı ile yapıldı. Yöntem: Çalışmaya, 45 Maraş Otu kullanıcısı (Grup I) ve sigara içen 32 kişi (Grup II), kontrol grubu olarak sigara veya Maraş Otu kullanmayan 30 sağlıklı olgu (Grup III) dahil edildi. Ventriküler repolarizasyon parametrelerini değerlendirmek için tüm olguların 50 mm/sn hızında elektrokardiyografileri çekildi. Ayrıca sistolik ve diyastolik fonksiyon parametreleri değerlendirmek için ekokardiyografik ölçümleri yapıldı. Bulgular: Her üç grupta da ventriküler repolarizasyon parametreleri arasında fark yoktu (p>0.05). Ekokardiyografik değerlendirmede üç grupta da sistolik fonksiyon parametreleri benzer bulundu. Grup I ve grup II'de sol ventrikül erken doluş zamanı kontrol grubuna göre daha düşüktü (p=0.03, p=0.02). Bu gruplarda, atriyal doluş zamanı (p=0.02, p=0.02) ve deselerasyon zamanı ise (p

🔖

Cite This Article

SÖKMEN, G., ÇAĞLAYAN, Ç. E., AKSU, E., GÜVEN, A., ÇETİNKAYA, A., BÜYÜKBEŞE, M. A., KÖKSAL, N. (2022). Farklı bir tip dumansız tütün kullanımının kardiyak parametreler üzerine etkisi: "Maraş otu". Anadolu Kardiyoloji Dergisi, Cilt: 3 - Sayı: 3, 230–235. https://ajindex.com/articles/437531

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. McBride PE. The health consequences of smoking. Cardiovascular diseases. Med Clin North Am 1992; 76: 333-8
  2. Qiao Q, Tervahauta M, Nissinen A, Tuomilehto J. Mortality from all cause and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. Eur Heart J 2000; 21: 1570-1
  3. Bartecchi CE, Mackenzie TD, Schrier RW. The human cost of tobacco use. N Engl J Med 1994;330:907-12
  4. Vlicatstra RE, Kronmal RA, Oberman A, Frye RL, Killip I. Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. JAMA 1986;255:1023-7
  5. Hallstrom AP, Cobb LA, Ray R. Smoking is a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 1986;314:271-5
  6. Barry J, Mead K, Nabel EG, et al. Effect of smoking on the activity of ischemic heart disease. JAMA 1989;261:398-402
  7. Cavender JB, Rogers WJ, Fisher LD, Gersh BJ, Coggin CJ, Myers WO. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators. J Am Coll Cardiol 1992;2:287-94
  8. Ozkul Y, Donmez H, Erenmemisoglu A, Demirtas H, Imamoglu N. Induction of micronuclei by smokeless tobacco on buccal mucosa cells of habitual users. Mutagenesis 1997;12:285-7
  9. Yamamoto K, Masuyama T, Tanouchi J,et al. Peak early diastolic filling velocity may decrease with preload augmentation: effect of concomitant increase in a rate of left atrial pressure drop in early diastole. J Am Soc Echocardiogr 1993;6:245-50
  10. Terry ML, Berkowitz HD, Kerstein MD. Tobacco. Its impact on vascular disease. Surg Clin North Am 1998;78:409-29
  11. Felding JE. Smoking: Health effects and control. N Engl J Med 1985;313:491-8
  12. Traber MG, Van der Vliet A, Reznick AZ, Cros CE. Smoking and pulmonary and cardiovascular diseases. Clin Chest Med 2000;2:173-87
  13. Farmer JA, Gotto AM. Dyslipidemia and other risk factors for coronary artery disease. In: Braunwald E. Editor. Heart Disease. A textbook of cardiovascular medicine. Philadelphia: WB Saunders Co; 1997. p.1126-61
  14. Rigotti NA, Pasternak RC. Cigarette smoking and coronary heart disease: risk and management. Cardiol Clin 1996;14:51-68
  15. Robertson D, Tseng JC, Appolsamy M. Smoking and mechanisms of cardiovascular control. Am Heart J 1988;115:258-66
  16. Benowitz N. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988; 319